Cart
sales@molnova.com
Hydroxyzine Pamoate
CAS No. 10246-75-0
Hydroxyzine Pamoate( Hydroxyzine pamoate )
Catalog No. M10113 CAS No. 10246-75-0
Hydroxyzine pamoate is a histamine H1-receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 42 | In Stock |
|
| 50MG | 72 | In Stock |
|
| 100MG | 120 | In Stock |
|
| 200MG | 160 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxyzine Pamoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyzine pamoate is a histamine H1-receptor antagonist.
-
DescriptionHydroxyzine pamoate is a histamine H1-receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsHydroxyzine pamoate
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number10246-75-0
-
Formula Weight763.27
-
Molecular FormulaC44H43ClN2O8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESClC1=CC=C(C(N2CCN(CCOCCO)CC2)C3=CC=CC=C3)C=C1.O=C(C4=C(O)C(CC5=C6C=CC=CC6=CC(C(O)=O)=C5O)=C7C=CC=CC7=C4)O
-
Chemical NameEthanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Spahr L, et al. Am J Gastroenterol. 2007 Apr;102(4):744-53.
molnova catalog
related products
-
KSK68
KSK68 is a potent dual sigma-1 and histamine H3 receptor antagonist with potential analgesic activity and high affinity for H3 receptors, sigma-1, sigma-2 receptors.KSK68 can be used in the study of pain related diseases.
-
GSK189254A
GSK189254A is a potent and specific histamine H3 receptor antagonist (pKi values: 9.59-9.90 and 8.51-9.17 for human and rat H3).
-
Propionyl-L-carnitin...
Levocarnitine propionate hcl is used to treat the deterioration of renal function, congestive heart failure, intermittent claudication, and other diseases.
